Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Sponsor: Mirum Pharmaceuticals, Inc.
Summary
This is a Phase 3, global, randomized, open-label, multicenter, trial evaluating brelovitug (BJT-778) vs bulevirtide for the treatment of chronic hepatitis delta infection (CHD). The main goal of this study is to test the effectiveness of brelovitug compared to bulevirtide as a long-term treatment in patients with chronic HDV infection.
Official title: A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
172
Start Date
2025-08-27
Completion Date
2029-09-30
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Brelovitug 300 mg
Route of administration- Subcutaneous Injection
Bulevirtide 2 mg and Brelovitug - 300 mg
Route of Administration- Subcutaneous Injection
Locations (44)
Medical University of Graz
Graz, Austria
Universitätsklinikum St. Pölten
Sankt Pölten, Austria
Fakultni Nemocnice Brno
Brno, Brno, Czechia
Fakultni Nemocnice Hradec Kralove
Hradec Králové, Hradec Králové, Czechia
Krajská nemocnice Liberec, a.s.
Liberec, Liberec, Czechia
Institute For Clinical And Experimental Medicine
Prague, Prague, Czechia
Klin Med s.r.o.
Prague, Prague, Czechia
Hôpital Estaing
Clermont-Ferrand, France
Hôpital Beaujon
Clichy, France
University Hospital Henri Mondor - APHP
Créteil, France
CHU Grenoble Alpes Hopital Nord Michallon
La Tronche, France
Site 512 Centre Hospitalier de Versailles _ Hopital Andre Magnot
Le Chesnay, France
University Hospital Limoges
Limoges, France
Hôpital de la Croix-Rousse
Lyon, France
Hôpital Pitié Salpêtrière
Paris, France
Centre Hospitalier Universitaire De Rennes
Rennes, France
Hôpital Rangueil
Toulouse, France
Goethe University Frankfurt
Frankfurt, Frankfurt, Germany
Rostock University Medical Center
Rostock, Rostock, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, Italy
National Institute Of Infectious Diseases
Bucharest, Bucharest, Romania
Spitalul Clinic De Boli Infectioase Si Tropicale Dr. Victor Babes
Bucharest, Bucharest, Romania
Centrul Medical Unirea S.R.L
Iași, Lasi, Romania
National Institute of Infectious Diseases Prof Dr Matei Bals
Bucharest, Romania
Spitalul Clinic de Boli Infectioase Constanta
Constanța, Romania
Hospital Universitario Torrecardenas
Almería, Almeria, Spain
Hospital Universitari Vall D Hebron
Barcelona, Barcelona, Spain
Hospital Clinic Provincial De Barcelona
Barcelona, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Hospital Universitario Álvaro Cunqueiro
Vigo, Spain
Karolinska University Hospital
Huddinge, Sweden
Hôpitaux Universitaires
Geneva, Canton of Geneva, Switzerland
HOCH Health Ostschweiz
Sankt Gallen, St.Gallen, Switzerland
Universitätsspital Zürich
Zurich, Switzerland
Queen Elizabeth Hospital Birmingham
Birmingham, Birmingham, United Kingdom
Chelsea and Westminster Hospital NHS Foundation Trust
London, London, United Kingdom
North Manchester General Hospital
Manchester, Manchester, United Kingdom
Hull University Teaching Hospitals
Cottingham, United Kingdom
Barts Health NHS Trust
London, United Kingdom
King's College Hospital NHS Foundation Trust
London, United Kingdom